pyridoxamine has been researched along with Cognitive Dysfunction in 1 studies
Cognitive Dysfunction: Diminished or impaired mental and/or intellectual function.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Our data indicate a protective effect of pyridoxamine against diabetes-induced cognitive deficits, and our comprehensive 'omics datasets provide insight into the pathogenesis of cognitive dysfunction enabling development of further mechanistic and therapeutic studies." | 7.91 | Cognitive dysfunction in diabetic rats is prevented by pyridoxamine treatment. A multidisciplinary investigation. ( Begley, P; Chevalier-Riffard, C; Church, SJ; Cooper, GJS; Dowsey, AW; Gardiner, NJ; Grayson, B; Kassab, S; Neill, JC; Phillips, AM; Rotariu, SM; Unwin, RD; Zeef, LAH, 2019) |
| "Our data indicate a protective effect of pyridoxamine against diabetes-induced cognitive deficits, and our comprehensive 'omics datasets provide insight into the pathogenesis of cognitive dysfunction enabling development of further mechanistic and therapeutic studies." | 3.91 | Cognitive dysfunction in diabetic rats is prevented by pyridoxamine treatment. A multidisciplinary investigation. ( Begley, P; Chevalier-Riffard, C; Church, SJ; Cooper, GJS; Dowsey, AW; Gardiner, NJ; Grayson, B; Kassab, S; Neill, JC; Phillips, AM; Rotariu, SM; Unwin, RD; Zeef, LAH, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kassab, S | 1 |
| Begley, P | 1 |
| Church, SJ | 1 |
| Rotariu, SM | 1 |
| Chevalier-Riffard, C | 1 |
| Dowsey, AW | 1 |
| Phillips, AM | 1 |
| Zeef, LAH | 1 |
| Grayson, B | 1 |
| Neill, JC | 1 |
| Cooper, GJS | 1 |
| Unwin, RD | 1 |
| Gardiner, NJ | 1 |
1 other study available for pyridoxamine and Cognitive Dysfunction
| Article | Year |
|---|---|
Cognitive dysfunction in diabetic rats is prevented by pyridoxamine treatment. A multidisciplinary investigation.
Topics: Animals; Cognitive Dysfunction; Diabetes Mellitus, Experimental; Hypoglycemic Agents; Male; Pyridoxa | 2019 |